Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
triamterene amiloride-sensitive sodium channel subunit alpha small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Hypokalemia[MeSHID:D007008]
Maintenance[MeSHID:D008283]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Neoplasm Metastasis[MeSHID:D009362]
Nephrotic Syndrome[MeSHID:D009404]
Hyperaldosteronism[MeSHID:D006929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 8.84 approved inhibitor
triamterene amiloride-sensitive sodium channel subunit alpha small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Hypokalemia[MeSHID:D007008]
Maintenance[MeSHID:D008283]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Neoplasm Metastasis[MeSHID:D009362]
Nephrotic Syndrome[MeSHID:D009404]
Hyperaldosteronism[MeSHID:D006929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 8.84 approved inhibitor,blocker
triamterene amiloride-sensitive sodium channel subunit beta small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Hypokalemia[MeSHID:D007008]
Maintenance[MeSHID:D008283]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Neoplasm Metastasis[MeSHID:D009362]
Nephrotic Syndrome[MeSHID:D009404]
Hyperaldosteronism[MeSHID:D006929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 5.3 approved inhibitor,blocker
triamterene amiloride-sensitive sodium channel subunit beta small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Hypokalemia[MeSHID:D007008]
Maintenance[MeSHID:D008283]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Neoplasm Metastasis[MeSHID:D009362]
Nephrotic Syndrome[MeSHID:D009404]
Hyperaldosteronism[MeSHID:D006929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 5.3 approved inhibitor
triamterene amiloride-sensitive sodium channel subunit delta small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Hypokalemia[MeSHID:D007008]
Maintenance[MeSHID:D008283]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Neoplasm Metastasis[MeSHID:D009362]
Nephrotic Syndrome[MeSHID:D009404]
Hyperaldosteronism[MeSHID:D006929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 8.84 approved inhibitor
triamterene amiloride-sensitive sodium channel subunit gamma small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Hypokalemia[MeSHID:D007008]
Maintenance[MeSHID:D008283]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Neoplasm Metastasis[MeSHID:D009362]
Nephrotic Syndrome[MeSHID:D009404]
Hyperaldosteronism[MeSHID:D006929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 8.84 approved inhibitor
triamterene amiloride-sensitive sodium channel subunit gamma small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Hypokalemia[MeSHID:D007008]
Maintenance[MeSHID:D008283]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Neoplasm Metastasis[MeSHID:D009362]
Nephrotic Syndrome[MeSHID:D009404]
Hyperaldosteronism[MeSHID:D006929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 8.84 approved inhibitor,blocker
click here to return to the previous page